Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation

NCT00255281 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: AZD7009, no generic name available

Sponsor

AstraZeneca